New injection could ease pain after bone surgery
NCT ID NCT07186426
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new drug called HSK21542 for pain after hip replacement surgery. About 405 adults will receive either HSK21542, morphine, or a placebo. The goal is to see if HSK21542 reduces pain better and causes fewer side effects like nausea and vomiting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HSK21542 injection
- What this could lead to
- If successful, this could provide a new option for managing pain after orthopedic surgery with potentially fewer side effects than current treatments.
- What could go wrong
- This is still an experimental drug. Even in Phase 3, it may not prove more effective or safer than existing painkillers like morphine. Side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Xiangya Hospital of Central South University
RECRUITINGChangsha, Hunan, China
-
Xuanwu Hospital Capital Medical University
RECRUITINGBeijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Chest surgery pain study seeks best relief strategy
- New study tests two injections to ease knee surgery pain and cut opioid use
- Eye-Opening pain relief: pupillometer may cut opioid use after surgery
- Hip surgery pain relief: which nerve block method works best?
- New hip block could match standard for Post-Surgery pain relief
- Pain education may boost shoulder surgery recovery